Analysts' Perspective: Palo Alto Networks' PT Raised, Agilent Technologies' PT Lowered
- May 24th, 2023
- 717 views
Palo Alto Networks, Inc. (Nasdaq: PANW) has seen a series of upward adjustments in its price target from various financial institutions. Deutsche Bank raised the price target from $210 to $225, Scotiabank increased it from $212 to $222, and Raymond James raised it from $215 to $230. RBC Capital Markets adjusted the target from $216 to $232, while Robert W. Baird raised it from $230 to $235. BMO Capital Markets increased the target from $228 to $235, and Wells Fargo adjusted it from $250 to $265. TD Cowen raised the target from $207 to $235, UBS from $200 to $220, and JP Morgan from $225 to $251. Other adjustments include Mizuho raising the target from $220 to $230, Stifel from $225 to $240, Credit Suisse from $235 to $260, Wolfe Research from $210 to $225, Evercore ISI from $215 to $240, BTIG Research from $240 to $253, Barclays from $235 to $245, and JMP Securities from $230 to $255.
Following these adjustments, $PANW is currently trading at $204.50, showing a significant increase of $14.76 (+7.78%).
On the other hand, Agilent Technologies, Inc. (NYSE: A) has experienced several downward adjustments in its price target. Credit Suisse lowered the target from $170 to $160, SVB Securities from $170 to $145, and Evercore ISI from $150 to $126. TD Cowen adjusted the target from $164 to $144, BofA Securities from $153 to $135, and Stifel from $174 to $144. Robert W. Baird lowered the target from $170 to $160, Wells Fargo from $150 to $130, Citigroup from $140 to $135, and Barclays from $140 to $135.
As a result of these adjustments, $A is currently trading at $115.78, experiencing a decrease of $12.86 (-10.00%).
THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY OR DIGITAL ASSET. Please consult with a professional investment advisor before purchasing or selling any securities viewed on or mentioned herein. (Read Full Disclaimer)
Tags
Post Your Comments
Want To Find Some News?
Recent Posts
-
Key Earnings Ahead for Netflix, Fastenal, and U.S. Bancorp
January 18th, 2026Louisville Thunder Appoints Veteran Coach Mike Reed to Lead Program
January 15th, 2026FDA Approves First Treatment for Children With Menkes Disease
January 13th, 2026January 13th, 2026Wall Street Eyes Bank of America, Wells Fargo, Citi Ahead of Earnings
January 11th, 2026




Member Login